http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 10 Mar 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Press+Releases/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html <p>NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd’s balance sheet.</p> <p>The sale is consistent with Creatd’s strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. http://www.streetinsider.com/Globe+Newswire/CRTD+%28Creatd+Inc.%29+Sells+Remaining+80%25+of+Fly+Flyte+to+NYSE-Listed+VTAK+%28Catheter+Precision+Inc.%29%2C+Securing+Significant+Cash+and+Equity+Position/26135693.html Tue, 10 Mar 2026 08:00:00 -0400 A.04733670 CRTDD O.00840169 O.02080835 O.53584208 VTAK http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html si-local-file:///var/storage/secattach/20260309/26133211.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html Mon, 09 Mar 2026 17:06:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html si-local-file:///var/storage/secattach/20260309/26133211.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html Mon, 09 Mar 2026 17:06:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html si-local-file:///var/storage/secattach/20260309/26133211.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Catheter+Precision%2C+Inc.++For%3A+Mar+06/26133211.html Mon, 09 Mar 2026 17:06:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html si-local-file:///var/storage/secattach/20260218/26022109.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html Wed, 18 Feb 2026 16:16:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html si-local-file:///var/storage/secattach/20260218/26022109.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html Wed, 18 Feb 2026 16:16:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html si-local-file:///var/storage/secattach/20260218/26022109.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Catheter+Precision%2C+Inc.++For%3A+Feb+12++Filed+by%3A+JENKINS+DAVID+A/26022109.html Wed, 18 Feb 2026 16:16:00 -0400 4RM O.00840169 VTAK http://www.streetinsider.com/Corporate+News/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html <p>Catheter Precision, Inc. (NYSE American: VTAK) acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB: CRTD), according to a company announcement. The transaction involved a secondary purchase from an existing shareholder.</p><p>Fly Flyte operates as a regional aviation service provider that uses artificial intelligence technology. The company provides services using certified aircraft and established routes, generating revenue while positioning for expansion.</p><p>"Creatd is committed to building a portfolio of operating companies in the small-cap space," said Jeremy Frommer, CEO of Creatd. "We see an opportunity to address the white space created by the contraction of middle http://www.streetinsider.com/Corporate+News/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html Tue, 17 Feb 2026 14:18:17 -0400 CRTD VTAK http://www.streetinsider.com/Corporate+News/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html <p>Catheter Precision, Inc. (NYSE American: VTAK) acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB: CRTD), according to a company announcement. The transaction involved a secondary purchase from an existing shareholder.</p><p>Fly Flyte operates as a regional aviation service provider that uses artificial intelligence technology. The company provides services using certified aircraft and established routes, generating revenue while positioning for expansion.</p><p>"Creatd is committed to building a portfolio of operating companies in the small-cap space," said Jeremy Frommer, CEO of Creatd. "We see an opportunity to address the white space created by the contraction of middle http://www.streetinsider.com/Corporate+News/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html Tue, 17 Feb 2026 14:18:17 -0400 CRTD VTAK http://www.streetinsider.com/Mergers+and+Acquisitions/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html <p>Catheter Precision, Inc. (NYSE American: VTAK) acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB: CRTD), according to a company announcement. The transaction involved a secondary purchase from an existing shareholder.</p><p>Fly Flyte operates as a regional aviation service provider that uses artificial intelligence technology. The company provides services using certified aircraft and established routes, generating revenue while positioning for expansion.</p><p>"Creatd is committed to building a portfolio of operating companies in the small-cap space," said Jeremy Frommer, CEO of Creatd. "We see an opportunity to address the white space created by the contraction of middle http://www.streetinsider.com/Mergers+and+Acquisitions/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html Tue, 17 Feb 2026 14:18:17 -0400 CRTD VTAK http://www.streetinsider.com/Mergers+and+Acquisitions/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html <p>Catheter Precision, Inc. (NYSE American: VTAK) acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB: CRTD), according to a company announcement. The transaction involved a secondary purchase from an existing shareholder.</p><p>Fly Flyte operates as a regional aviation service provider that uses artificial intelligence technology. The company provides services using certified aircraft and established routes, generating revenue while positioning for expansion.</p><p>"Creatd is committed to building a portfolio of operating companies in the small-cap space," said Jeremy Frommer, CEO of Creatd. "We see an opportunity to address the white space created by the contraction of middle http://www.streetinsider.com/Mergers+and+Acquisitions/VTAK+acquires+20%25+stake+in+Creatd%27s+aviation+subsidiary+Fly+Flyte/26011056.html Tue, 17 Feb 2026 14:18:17 -0400 CRTD VTAK http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html <ul><li style="text-align:left;"><strong>Strategic Partnership:</strong> Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary.</li><li><strong>Portfolio Expansion:</strong> Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.<br/></li><li style="margin-bottom:12pt;"><strong>Innovation in Aviation:</strong> Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations.<br/></li></ul> <p>NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd’s strategy of nurturing technology-enabled subsidiaries http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html Tue, 17 Feb 2026 14:17:00 -0400 CRTD O.00840169 O.02080835 VTAK http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html <ul><li style="text-align:left;"><strong>Strategic Partnership:</strong> Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary.</li><li><strong>Portfolio Expansion:</strong> Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.<br/></li><li style="margin-bottom:12pt;"><strong>Innovation in Aviation:</strong> Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations.<br/></li></ul> <p>NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd’s strategy of nurturing technology-enabled subsidiaries http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html Tue, 17 Feb 2026 14:17:00 -0400 CRTD O.00840169 O.02080835 VTAK http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html <ul><li style="text-align:left;"><strong>Strategic Partnership:</strong> Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary.</li><li><strong>Portfolio Expansion:</strong> Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.<br/></li><li style="margin-bottom:12pt;"><strong>Innovation in Aviation:</strong> Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations.<br/></li></ul> <p>NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd’s strategy of nurturing technology-enabled subsidiaries http://www.streetinsider.com/Press+Releases/VTAK+Acquires+20%25+Interest+in+Creatd%E2%80%99s+Subsidiary+Fly+Flyte%2C+Inc./26011053.html Tue, 17 Feb 2026 14:17:00 -0400 CRTD O.00840169 O.02080835 VTAK